Association of Apical Periodontitis With Systemic Level of Inflammatory Markers : A Longitudinal Intervention Study
1 other identifier
interventional
280
1 country
1
Brief Summary
While cross-sectional studies have reported a significant association between diabetes and Apical Periodontics, prospective studies are scarce. This will be the first prospective interventional study to explore the cause-and-effect relation between AP and diabetes by assessment of levels of inflammatory markers in a longitudinal setting. Periapical healing in diabetics and nondiabetics will be compared after root canal treatment to evaluate the role of various physical and metabolic attributes on endodontic outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Apr 2023
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2023
CompletedStudy Start
First participant enrolled
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 18, 2023
April 1, 2023
1.7 years
April 3, 2023
April 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
PAI SCORE
PERIAPICAL INDEX RADIOGRAPHIC EVALUATION
12 MONTHS
Interlukin 1B
INFLAMMATORY MARKER BY ELISA KIT
12 MONTHS
IL 6
ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT
12 MONTHS
TNF -ALPHA
ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT
12 MONTHS
hs-CRP
ESTIMATION OF NFLAMMATORY MARKER BY ELISA KIT
12 MONTHS
Study Arms (4)
Diabetic patients with Apical periodontitis
EXPERIMENTALDiabetic patients with Apical periodontitis received Endodontics treatment in form of Root canal treatment and assessment of inflammatory and metabolic markers
Healthy patients with Apical periodontitis
EXPERIMENTALsystemically healthy participants patients with Apical periodontitis received Endodontics treatment in the form of root canal treatment and assessment of inflammatory markers
Diabetic patients with out Apical periodontitis
ACTIVE COMPARATORsystemic inflammatory markers along with metabolic markers will be assessed
Healthy participants without Apical periodontitis
ACTIVE COMPARATORsystemic inflammatory markers will be assessed
Interventions
Patients will receive endodontic treatment, and inflammatory markers will be assessed
Patients will receive endodontic treatment in the form of root canal treatment, and inflammatory markers will be assessed along with metabolic markers assessment
assessment of inflammatory markers
inflammatory markers will be assessed along with metabolic markers assessment
Eligibility Criteria
You may qualify if:
- Patients 30-55 year age group with minimum 20 natural teeth, with pulp necrosis confirmed by cold test and electric pulp test and radiographic evidence of periapical radiolucency with PAI score of ≥3 (24) or more in at least one mature tooth.
- control in the systemically healthy group will be selected to match participants in terms of age, sex, and BMI.
- control for participants with type 2 DM will be selected to additionally match with glycaemic control, drugs and dietary measures apart from other physical attributes.
You may not qualify if:
- Patients with clinical diagnosis of moderate to severe periodontitis (≥6 sites with probing depth ≥5 mm at separate teeth, with attachment loss and radiographic alveolar bone loss), Patients with immunosuppression, pregnancy, conditions requiring prophylactic antibiotics prior to dental treatment, bleeding disorders, medical conditions that may affect study participation (e.g., unstable cardiovascular disease) and chronic inflammatory conditions like rheumatoid
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PGIDS
Rohtak, Haryana, 124001, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
SANJAY TEWARI
POST GRADUATE INSTITUTE OF DENTAL SCIENCES,ROHTAK
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2023
First Posted
April 18, 2023
Study Start
April 5, 2023
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
April 18, 2023
Record last verified: 2023-04